Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mary-Krause

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Revue D'Epidemiologie Et De Sante Publique|January 1, 1993
Conditions of validation and use of the screening method for vaccine efficacy evaluationM Mary-Krause, J Y Mary, A J Valleron
Circulation|February 7, 2001
Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II)T Simon, M Mary-Krause, C Funck-Brentano, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 25, 2006
[Flecainide controlled-release for prevention of atrial fibrillation relapse]T Simon, M Mary-Krause, A Chatelin, et al.
Pharmacoepidemiology and Drug Safety|March 8, 2008
Influence of control selection in nested case-control studies: the example of exposure to antiretroviral treatment (ART) and the risk of myocardial infarction (MI) in the French Hospital Database on HIV (FHDH-ANRS CO4)M Guiguet, M Mary-Krause, B Ename, et al.
HIV Medicine|November 16, 2006
Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment responseL Fardet, M Mary-Krause, I Heard, et al.
European Heart Journal|March 20, 2003
Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II)T Simon, M Mary-Krause, C Funck-Brentano, et al.
Journal of the American College of Cardiology|June 1, 1996
Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery diseaseT Madjlessi-Simon, M Mary-Krause, F Fillette, et al.
European Heart Journal|December 1, 1995
Effects of amlodipine on transient myocardial ischaemia in patients with a severe coronary condition treated with a beta-blocker. Amlor-Holter Study InvestigatorsT Madjlessi-Simon, F Fillette, M Mary-Krause, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 26, 2002
[Efficacy and tolerance of propafenone after correction of atrial fibrillation: PEPS pharmaco-epidemiologic study]T Simon, M Mary-Krause, C Funck-Brentano, et al.
Clinical Pharmacology and Therapeutics|May 9, 2000
Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicityT Simon, L Becquemont, M Mary-Krause, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Revue D'Epidemiologie Et De Sante Publique|January 1, 1993
Conditions of validation and use of the screening method for vaccine efficacy evaluationM Mary-Krause, J Y Mary, A J Valleron
Circulation|February 7, 2001
Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II)T Simon, M Mary-Krause, C Funck-Brentano, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 25, 2006
[Flecainide controlled-release for prevention of atrial fibrillation relapse]T Simon, M Mary-Krause, A Chatelin, et al.
Pharmacoepidemiology and Drug Safety|March 8, 2008
Influence of control selection in nested case-control studies: the example of exposure to antiretroviral treatment (ART) and the risk of myocardial infarction (MI) in the French Hospital Database on HIV (FHDH-ANRS CO4)M Guiguet, M Mary-Krause, B Ename, et al.
HIV Medicine|November 16, 2006
Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment responseL Fardet, M Mary-Krause, I Heard, et al.
European Heart Journal|March 20, 2003
Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II)T Simon, M Mary-Krause, C Funck-Brentano, et al.
Journal of the American College of Cardiology|June 1, 1996
Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery diseaseT Madjlessi-Simon, M Mary-Krause, F Fillette, et al.
European Heart Journal|December 1, 1995
Effects of amlodipine on transient myocardial ischaemia in patients with a severe coronary condition treated with a beta-blocker. Amlor-Holter Study InvestigatorsT Madjlessi-Simon, F Fillette, M Mary-Krause, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 26, 2002
[Efficacy and tolerance of propafenone after correction of atrial fibrillation: PEPS pharmaco-epidemiologic study]T Simon, M Mary-Krause, C Funck-Brentano, et al.
Clinical Pharmacology and Therapeutics|May 9, 2000
Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicityT Simon, L Becquemont, M Mary-Krause, et al.
Pageof 2